Brief: Kontafarma China Sees HY Consol Net Loss Of HK$67.2 Million-HK$100.7 Million
17/08/2026 16:11
BRIEF-Kontafarma China Sees HY Consol Net Loss Of HK$67.2 Million-HK$100.7 Million Aug 17 (Reuters) - Kontafarma China Holdings Ltd 1312.HK:
EXPECTS CONSOLIDATED NET LOSS OF HK$67.2 MILLION-HK$100.7 MILLION FOR SIX MONTHS ENDED 30 JUNE 2026
EXPECTED HY RESULT AS IMPAIRMENT LOSS ON RIGHT-OF-USE ASSETS AT HK$9.7 MILLION-HK$14.6 MILLION, OTHERS
Further company coverage: 1312.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kontafarma China Holdings
See all newsBrief: Kontafarma China Holdings Announces Creditors' Voluntary Winding-Up Of Singapore Subsidiaries
Brief: Kontafarma China Appoints Li Qingshan As Executive Director And President
Brief: Kontafarma China Sees HY Consol Net Loss Of HK$67.2 Million-HK$100.7 Million
Brief: Kontafarma China Appoints Wang Limin As Executive Director, Chairman And President
Brief: Kontafarma China Announces Resignation Of Liu Jiankun As Executive Director Effective 16 Apr